Literature DB >> 16965351

The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses.

Kazuto Kiura1, Hideo Kataoka, Motoaki Yasuda, Nobuo Inoue, Ken-ichiro Shibata.   

Abstract

The diacylated lipopeptide FSL-1 enhanced the generation of IgG antibodies in TLR2(+/+) mice, but not in TLR2(-/-) mice, when administered together with hen egg lysozyme as an antigen. Escherichia coli lipopolysaccharide enhanced the generation of antigen-specific antibodies in both TLR2(-/-) and TLR2(+/+) mice. In TLR2(+/+) mice, the level of enhancement due to FSL-1 was similar to that caused by lipopolysaccharide. Analysis of the IgG antibodies subclass demonstrated that the level of Th2-type IgG1 antibodies was higher than that of Th1-type IgG2a antibodies. Both FSL-1 and lipopolysaccharide induced production of IL-10 and IL-6 by splenocytes from TLR2(+/+) mice. Lipopolysaccharide also induced production of these cytokines by splenocytes from TLR2(-/-) mice, but FSL-1 did not. Neither FSL-1 nor lipopolysaccharide induced IL-12p70 production by splenocytes from either type of mice. FSL-1 upregulated B7.2 expression in B220(+) cells from TLR2(+/+) mice but not those from TLR2(-/-) mice, whereas lipopolysaccharide upregulated B7.2 expression in B220(+) cells from both types of mice. FSL-1 and, to a lesser extent, lipopolysaccharide activated mitogen-activated protein kinases in splenocytes. FSL-1 and, to a lesser extent, lipopolysaccharide induced the expression of c-Fos, which is known to be involved in Th2-type responses, in splenocytes. Thus, this study demonstrated that FSL-1 possessed TLR2-mediated Th2-type responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965351     DOI: 10.1111/j.1574-695X.2006.00119.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  26 in total

Review 1.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  Structure-activity relationships in toll-like receptor 2-agonists leading to simplified monoacyl lipopeptides.

Authors:  Geetanjali Agnihotri; Breanna M Crall; Tyler C Lewis; Timothy P Day; Rajalakshmi Balakrishna; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

Review 3.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

4.  The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2.

Authors:  Haque M Shamsul; Akira Hasebe; Mitsuhiro Iyori; Makoto Ohtani; Kazuto Kiura; Diya Zhang; Yasunori Totsuka; Ken-ichiro Shibata
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

5.  Assessment of Lactobacillus gasseri as a candidate oral vaccine vector.

Authors:  Laura Stoeker; Shila Nordone; Sara Gunderson; Lin Zhang; Akinobu Kajikawa; Alora LaVoy; Michael Miller; Todd R Klaenhammer; Gregg A Dean
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

6.  Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2+ Monocytes.

Authors:  Christopher T Johndrow; Michael F Goldberg; Alison J Johnson; Tony W Ng; Shajo Kunnath-Velayudhan; Gregoire Lauvau; Daniel H Kaplan; Graeme H Gossel; Ulrich D Kadolsky; Andrew J Yates; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2018-11-19       Impact factor: 5.422

7.  Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Isabel Devesa; Mieke F Roelofs; Timothy R D J Radstake; Marleen Heuvelmans-Jacobs; Shizuo Akira; Martin J H Nicklin; Fátima Ribeiro-Dias; Wim B van den Berg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Nitrogen dioxide promotes allergic sensitization to inhaled antigen.

Authors:  Mieke Bevelander; Jana Mayette; Laurie A Whittaker; Sara A Paveglio; Christine C Jones; Justin Robbins; David Hemenway; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 10.  Modulation of adaptive immunity with Toll-like receptors.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Semin Immunol       Date:  2009-06-06       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.